Table 1.

Demographic Information

	Minocycline (N=28)	Placebo (N=23)
Age (years)	42.9 ± 14.2	42.3 ± 11.0
Race	18 White (64%) 8 Black (29%)	13 White (57%) 8 Black (35%)
Sex (male)	20 (71%)	18 (78%)
Age of Illness Onset	18.5 ± 6.2	19.3 ± 5.7
Level of Education	12.1 ± 1.6	12.2 ± 2.6
Inpatients	11 (39%)	7 (30%)
Clozapine dose (mg/day)	423.1 ± 189.5	433.7 ± 140.1
Total Clozapine level (ng/mL)	777.4 ± 392.8	816.6 ± 339.5
Clozapine (ng/mL)	489.5 ± 257.1	517.7 ± 211.2
Norclozapine (ng/mL)	287.9 ± 165.0	298.9 ± 172.6
Other Antipsychotic	13 (46%)	8 (35%)
First Generation	4 (14%)	1 (4%)
Second Generation	9 (32%)	7 (30%)
Antidepressant	14 (50%)	8 (35%)
Mood Stabilizer	10 (36%)	6 (26%)
Anticholinergic	4 (14%)	3 (13%)
Benzodiazepine	15 (54%)	9 (39%)